Quick Answer
NOVAVAX INC reported Shares Outstanding of 162.58 million shares for fiscal year 2025.
NOVAVAX INC Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 162.58M | +1.3% |
| 2024 | 160.42M | +15.0% |
| 2023 | 139.51M | +62.1% |
| 2022 | 86.04M | +13.4% |
| 2021 | 75.84M | +6.9% |
| 2020 | 70.95M | +119.3% |
| 2019 | 32.35M | +68.3% |
| 2018 | 19.22M | -94.1% |
| 2017 | 323.23M | +19.2% |
| 2016 | 271.25M | +0.5% |
| 2015 | 269.97M | +13.0% |
| 2014 | 238.83M | +14.5% |
| 2013 | 208.66M | +41.0% |
| 2012 | 147.94M | +26.4% |
| 2011 | 117.03M | +5.4% |
| 2010 | 111.04M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 162.47M | +1.4% | +0.2% |
| June 30, 2025 | 162.16M | +1.4% | +0.1% |
| March 31, 2025 | 161.96M | +15.4% | +1.0% |
| December 31, 2024 | 160.42M | +15.0% | +0.2% |
| September 30, 2024 | 160.15M | +34.9% | +0.2% |
| June 30, 2024 | 159.89M | +69.5% | +13.9% |
| March 31, 2024 | 140.37M | +62.7% | +0.6% |
| December 31, 2023 | 139.51M | +62.1% | +17.5% |
- NOVAVAX INC showed an increase of +1.3% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, NOVAVAX INC’s shares outstanding has grown by 46.4% (from 111.04 million shares to 162.58 million shares).
- The most recent figure is from NOVAVAX INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: